Case | Anticoagulant | Occurred at days of anticoagulation | Tumor type | Bleeding site |
---|---|---|---|---|
1 | Nadroparin | 137 | gastrointestinal | gastrointestinal |
2 | Nadroparin | 64 | lymphoma | subcutaneous |
3 | Rivaroxaban | 139 | lymphoma | subcutaneous |
4 | Nadroparin | 106 | breast | hematuria |
5 | Rivaroxaban | 44 | gynecology | hematuria |
6 | Rivaroxaban | 65 | gastrointestinal | gastrointestinal |
7 | Rivaroxaban | 61 | lung | epistaxis |
8 | Rivaroxaban | 83 | breast | hematuria |
9 | Rivaroxaban | 98 | breast | subcutaneous |
10 | Rivaroxaban | 181 | breast | hematuria |
11 | Rivaroxaban | 63 | breast | gastrointestinal |
12 | Nadroparin | 163 | breast | gastrointestinal |
13 | Nadroparin | 152 | breast | hematuria |
14 | Rivaroxaban | 26 | gynecology | gastrointestinal |
15 | Rivaroxaban | 179 | gastrointestinal | subcutaneous |
16 | Nadroparin | 110 | gynecology | hematuria |
17 | Rivaroxaban | 39 | gastrointestinal | epistaxis |
18 | Rivaroxaban | 163 | lung | hemoptysis |
19 | Rivaroxaban | 79 | lung | hemoptysis |